Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COMMON STOCK-FO
-
Number of holders
-
250
-
Total 13F shares, excl. options
-
155,837,654
-
Shares change
-
+153,375,543
-
Total reported value, excl. options
-
$3,748,757,857
-
Value change
-
+$3,689,401,958
-
Put/Call ratio
-
154%
-
Number of buys
-
242
-
Number of sells
-
-6
-
Price
-
$24.06
Significant Holders of HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) as of Q2 2019
271 filings reported holding HZNP - HORIZON THERAPEUTICS PLC - COMMON STOCK-FO as of Q2 2019.
HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) has 250 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 155,837,654 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (16,594,128 shares), BlackRock Inc. (11,379,280 shares), RENAISSANCE TECHNOLOGIES LLC (8,754,275 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (6,958,303 shares), PAULSON & CO. INC. (6,670,700 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (6,462,634 shares), D. E. Shaw & Co., Inc. (5,097,929 shares), FMR LLC (5,096,996 shares), JPMORGAN CHASE & CO (5,090,627 shares), and DIMENSIONAL FUND ADVISORS LP (4,787,962 shares).
This table shows the top 250 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.